From October 1, 2023 to December 31, 2023, the company has repurchased 1,100,000 shares, representing 1.3% for $231.55 million. With this, the company has completed the repurchase of 12,359,458 shares, representing 13.58% for $2,950.82 million under the buyback announced on December 9, 2021.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
198.4 USD | +0.03% | -1.53% | -12.71% |
Apr. 26 | Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255 | MT |
Apr. 26 | Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.71% | 16.73B | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B | |
-3.97% | 11.66B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on December 9, 2021.